Flutiform (Affilia) Innúðalyf, dreifa 250 míkróg/10 míkróg Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

flutiform (affilia) innúðalyf, dreifa 250 míkróg/10 míkróg

mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 250 míkróg/10 míkróg

Flutiform (Affilia) Innúðalyf, dreifa 50 míkróg/5 míkróg Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

flutiform (affilia) innúðalyf, dreifa 50 míkróg/5 míkróg

mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 50 míkróg/5 míkróg

Arexvy Europäische Union - Isländisch - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - sýkingar af völdum sýklalyfja - bóluefni - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.